BIO Submits Comments on CDC Clinical Practice Guideline for Prescribing Opioids
April 11, 2022
On Monday, April 11th, BIO also submitted comments in response to the CDC’s recently published Clinical Practice Guideline for Prescribing Opioids. In the comments submitted, BIO primarily requested that the CDC revise its language referencing naloxone to be consistent with more general and product agnostic references, e.g., FDA-approved opioid overdose reversal medication.
Download Full Comments Below
BIO COMMENT LETTER CDC Guideline for Prescribing Opioids